A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information.
By designing an algorithm and developing it to analyse CT scan images, medical researchers at Gustave Roussy, CentraleSupélec, Inserm, Paris-Sud University and TheraPanacea (spin-off from CentraleSupélec specialising in artificial intelligence in oncology-radiotherapy and precision medicine) have created a so-called radiomic signature. This signature defines the level of lymphocyte infiltration of a tumour and provides a predictive score for the efficacy of immunotherapy in the patient.
In the future, physicians might thus be able to use imaging to identify biological phenomena in a tumour located in any part of the body without having to perform a biopsy.
Up to now, no marker can accurately identify those patients who will respond to anti-PD-1/PD-L1 immunotherapy in a situation where only 15 to 30% of patients do respond to such treatment. It is known that the richer the tumour environment is immunologically (presence of lymphocytes) the greater the chance that immunotherapy will be effective, so the researchers have tried to characterise this environment using imaging and correlate this with the patients’ clinical response. Such is the objective of the radiomic signature designed and validated in the study published in The Lancet Oncology.
In this retrospective study, the radiomic signature was captured, developed and validated in 500 patients with solid tumours (all sites) from four independent cohorts. It was validated genomically, histologically and clinically, making it particularly robust.
Using an approach based on machine learning, the team first taught the algorithm to use relevant information extracted from CT scans of patients participating in the MOSCATO* study , which also held tumor genome data. Thus, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumour immune infiltrate, in particular with respect to the presence of cytotoxic T-lymphocytes (CD8) in the tumour, and it established a radiomic signature.
This signature was tested and validated in other cohorts including that of TCGA (The Cancer Genome Atlas) thus showing that imaging could predict a biological phenomenon, providing an estimation of the degree of immune infiltration of a tumour.
Then, to test the applicability of this signature in a real situation and correlate it to the efficacy of immunotherapy, it was evaluated using CT scans performed before the start of treatment in patients participating in 5 phase I trials of anti-PD-1/PD-L1 immunotherapy. It was found that the patients in whom immunotherapy was effective at 3 and 6 months had higher radiomic scores as did those with better overall survival.
The next clinical study will assess the signature both retrospectively and prospectively, will use larger numbers of patients and will stratify them according to cancer type in order to refine the signature.
This will also employ more sophisticated automatic learning and artificial intelligence algorithms to predict patient response to immunotherapy. To that end, the researchers are intending to integrate data from imaging, molecular biology and tissue analysis. This is the objective of the collaboration between Gustave Roussy, Inserm, Université Paris-Sud, CentraleSupélec and TheraPanacea to identify those patients who are the most likely to respond to treatment, thus improving the efficacy/cost ratio of the treatment.
Learn more: Predicting the response to immunotherapy using artificial intelligence
The Latest on: Artificial intelligence
[google_news title=”” keyword=”artificial intelligence” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial intelligence
- Powered by OriginTrail, ChatDKG.AI is unlocking a Truly Open Artificial Intelligenceon May 9, 2024 at 11:26 am
Inception program open for application Those looking to build the next big thing with ChatDKG’s trusted AI solution or launch an Initial Paranet Offering are able to submit their application for the ...
- TikTok to start labeling AI-generated content as technology becomes more universalon May 9, 2024 at 10:30 am
TikTok will begin labeling content created using artificial intelligence when it's uploaded from outside its own platform. TikTok says its efforts are an attempt to combat misinformation from being ...
- Artificial intelligence at the root of a real tourism revolution - Part 2on May 9, 2024 at 8:33 am
The tourism sector is constantly evolving as new technologies enter the market. After taking an interest in metaverse, virtual and augmented reality, it's now artificial intelligence's turn to shake ...
- ‘Sic AI’s on each other’ to solve artificial intelligence threat: David Brin, authoron May 9, 2024 at 8:30 am
Best-selling sci-fi author David Brin says AIs could be made to police each other under threat of losing blockchain-based registration.
- Explainer: How dependent is China on US artificial intelligence technology?on May 9, 2024 at 7:29 am
The Biden administration plans to put guardrails on U.S.-developed artificial intelligence (AI) models that power popular chatbots like ChatGPT to safeguard the technology from countries such as China ...
- Artificial Intelligence ‘Friends’on May 9, 2024 at 3:48 am
Artificial intelligence, we are told, is a transformative economic force; it will change workers’ jobs, boost corporate profits and reshape industries. But for the last month, I’ve been investigating ...
- Elon Musk’s Artificial Intelligence Startup xAI Reportedly Nears $18 Billion Valuation With Fresh Funding As AI Race Heats Upon May 9, 2024 at 3:03 am
The funding would provide Musk’s venture, which is behind the Grok AI chatbot, a welcome boost in its efforts to catch up to AI rivals like OpenAI, Google and Anthropic.
- Department of Homeland Security pilots new Artificial Intelligence program for immigration processon May 9, 2024 at 2:10 am
The program seeks to train officers to review applicants for refugee states in the U.S.. The machine would not make asylum decisions.
- 2 Millionaire-Maker Artificial Intelligence (AI) Stockson May 9, 2024 at 1:55 am
Snowflake ( SNOW -0.82%) and Super Micro Computer ( SMCI 0.41%) have become pivotal in the development and growth of artificial intelligence (AI) technology. These stocks have the ingredients to ...
- Colorado Legislature Passes First-in-Nation Artificial Intelligence Billon May 8, 2024 at 5:00 pm
Keypoint: If signed into law, Colorado will become the first state to enact legislation regulating the use of high-risk artificial intelligence systems. On May 8, the Colorado legislature passed the ...
via Bing News